Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Moriggia

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Therapeutische Umschau. Revue Therapeutique|August 5, 2017
Alberto Moriggia, Felix Stickel
Swiss Medical Weekly|March 25, 2019
Controlling HCV in Switzerland: running against the clockAndreas Cerny, Raoul Blindenbacher, Alberto Moriggia
Journal of Medical Virology|April 23, 2008
Changes in circulation of B and non-B HIV strains: spotlight on a reference centre for infectious diseases in Northern ItalyFausto Baldanti, Stefania Paolucci, Giovanni Ravasi, et al.
Swiss Medical Weekly|March 11, 2021
Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohortAndrea Bregenzer, Philip Bruggmann, Erika Castro, et al.
Plos One|May 27, 2016
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening RecommendationsBarbara Bertisch, Fabio Giudici, Francesco Negro, et al.
Harm Reduction Journal|June 19, 2019
Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug usersSalequl Islam, Damani A Piggott, Alberto Moriggia, et al.
Swiss Medical Weekly|December 18, 2019
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030Nicolas Goossens, Stefano Bellentani, Andreas Cerny, et al.
Drug and Alcohol Dependence Reports|January 19, 2026
Characteristics and comorbidities of patients on opioid agonist therapy in Switzerland: A descriptive analysis of the nationwide SAMMSU cohortMichael Lütolf, Andrea Bregenzer, Philip Bruggmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?Barbara Bertisch, Matteo Brezzi, Francesco Negro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject DrugsEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapeutische Umschau. Revue Therapeutique|August 5, 2017
Alberto Moriggia, Felix Stickel
Swiss Medical Weekly|March 25, 2019
Controlling HCV in Switzerland: running against the clockAndreas Cerny, Raoul Blindenbacher, Alberto Moriggia
Journal of Medical Virology|April 23, 2008
Changes in circulation of B and non-B HIV strains: spotlight on a reference centre for infectious diseases in Northern ItalyFausto Baldanti, Stefania Paolucci, Giovanni Ravasi, et al.
Swiss Medical Weekly|March 11, 2021
Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohortAndrea Bregenzer, Philip Bruggmann, Erika Castro, et al.
Plos One|May 27, 2016
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening RecommendationsBarbara Bertisch, Fabio Giudici, Francesco Negro, et al.
Harm Reduction Journal|June 19, 2019
Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug usersSalequl Islam, Damani A Piggott, Alberto Moriggia, et al.
Swiss Medical Weekly|December 18, 2019
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030Nicolas Goossens, Stefano Bellentani, Andreas Cerny, et al.
Drug and Alcohol Dependence Reports|January 19, 2026
Characteristics and comorbidities of patients on opioid agonist therapy in Switzerland: A descriptive analysis of the nationwide SAMMSU cohortMichael Lütolf, Andrea Bregenzer, Philip Bruggmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?Barbara Bertisch, Matteo Brezzi, Francesco Negro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject DrugsEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Pageof 2